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ABSTRACT 
Background  
Hospital Acquired Pneumonia is a significant burden to healthcare systems around the world.  
Although there is a considerable body of evidence on prevention of Ventilator Associated 
Pneumonia, less is known about strategies to prevent hospital-acquired pneumonia in non-
critical care settings.   
 
Objective 
To systematically review the Randomised Controlled Trial evidence for prevention of 
hospital-acquired pneumonia in non-critical care settings.   
 
Methods  
We searched EMBASE, CINAHL+, MEDLINE and the Cochrane Library.  Seventeen 
different searches were conducted in parallel through each database.  Studies were included if 
they were randomised controlled trials reporting hospital-acquired pneumonia as an endpoint. 
Studies were excluded if they were performed in critical care or community settings.  All 
studies published up to the end of December 2014 were considered, with no language 
restrictions. Data were independently extracted by two authors and the Delphi risk of bias 
tool was applied to assess trial quality. 
 
Results  
5101 titles were identified across 17 searches. Only 2 studies were eligible for inclusion in 
the final review, one from a search of physical therapy interventions and one from a search of 
enteral feeding.  The heterogeneity of the interventions did not permit meta-analysis.  One 
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trial suggested possible benefits to early mobilisation; the other trial suggested no benefit or 
harm from early enteral feeding via nasogastric tube. Both trials enrolled patients with acute 
stroke. No trials in non-stroke, non-critical care populations were eligible for inclusion in the 
review. 
 
Conclusions 
There is currently insufficient trial evidence on preventing non-critical care hospital-acquired 
pneumonia to make recommendations on practice.  
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INTRODUCTION 
Hospital Acquired Pneumonia (HAP) is a major source of morbidity and mortality[1-6]. 
Whilst considerable effort has been made to study and prevent ventilator-acquired pneumonia 
(VAP)[7], much less is known about hospital-acquired pneumonia outside critical care 
facilities. The estimated prevalence of non-critical care HAP is uncertain; estimates vary 
between 1% and 8% of hospital admissions depending on the subgroup of patients studied, 
with older people being at particular risk.  HAP is associated with a mortality rate of up to 
70% either as a direct consequence or contributing to other factors.  It typically adds 7-9 days 
onto a hospital admission[8], and hence carries significant financial burden. 
 
The aetiopathogenesis of HAP is thought to be an interaction between microaspiration or 
macroaspiration of oral flora, impaired defence mechanisms (for example impaired cough 
reflexes, reduced mucociliary escalator activity, impaired pulmonary immunity) and, at least 
for some patient populations,  changes to oral flora as a result of residence in hospital and 
exposure to antimicrobial agents[9]. Treatment of hospital acquired pneumonia requires 
additional antimicrobial therapy, may involve treatment of resistant organisms, and each 
episode of infection is likely to produce deleterious effects on physical function, 
cardiovascular events, delirium, nutrition and psychological status. It is thus important to find 
ways to prevent hospital acquired pneumonia outside the critical care environment. 
 
Although interventions to prevent VAP have been well studied, and several effective 
interventions are known[7], interventions to prevent hospital acquired pneumonia outside 
critical care units are much less studied, and to date, no systematic review has synthesised the 
trial evidence in non-critical care settings.  In this paper, we report the results of a systematic 
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review of interventions to prevent non-critical care HAP as a starting point for future 
development of interventions to prevent this condition. 
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METHODS 
Scope of review 
Following a preliminary literature search, an expert panel consisting of the authors was 
convened, with representation from geriatric medicine, infectious diseases and microbiology. 
Candidate interventions were identified and discussed based on observational data, use in 
critical care settings, biological plausibility and topical interest. A range of pharmacological 
and non-pharmacological interventions were identified for review, and the review was 
conducted according to a prespecified protocol based on the PRISMA guidelines[10].   
 
Inclusion & Exclusion criteria 
The systematic review sought to include only randomised controlled trials of interventions to 
reduce HAP in the non critical care setting.  Studies comparing intervention with either  
placebo or usual care, or comparing two different interventions were included in the analysis.  
Both parallel group and crossover studies were eligible for inclusion.  Studies examining 
community-acquired pneumonia or pneumonia acquired in non-hospital healthcare facilities 
(e.g. nursing homes) were excluded, as were those which examined VAP.   
 
Data sources and search strategies 
MEDLINE, CINAHL+ and EMBASE databases were searched; search results up to 
December 31
st
 2014were included.  The Cochrane library was also checked for original 
research and systematic reviews on HAP.  References of included papers were hand searched 
to identify other papers of interest. No language restrictions were applied to the searches. The 
search strategies used are included in Appendix A. 
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Interventions 
17 interventions were examined in three different groups:  Group A ‘Patient based 
Interventions’ such as risk assessment and mouthwash; Group B ‘Medications’ including 
sedatives, anti-emetics and pro-kinetics; and Group C ‘Staff Interventions & Environmental 
Factors’ including handwashing, staff education and deep cleaning.  The full search strategy 
is attached in Appendix A. 
 
Outcomes 
The primary outcome we sought to extract was the incidence of HAP.  Secondary outcome 
measures were mortality, length of stay, use of multiple antibiotics and total number of days 
of antibiotic therapy.  Data were also extracted on age, sex, description of intervention, 
comorbid disease, medication use and a description of the healthcare setting. 
 
Data extraction and quality assessment 
Standardised proformas for data extraction and quality assessment were used. Selection of 
abstracts and full papers for retrieval was performed by two authors (SMcA and MDW) with 
differences in selection resolved by consensus. Data from included papers were extracted 
independently by two authors (SMcA and MDW), with differences resolved by consensus. 
Risk of bias assessment was performed using categories from the Delphi risk of bias tool[11].  
 
Data synthesis 
For each of the 17 searches, we aimed to combine incidence data from similar studies by 
meta-analysis via Peto odds ratios using random-effects modelling. Where studies were too 
dissimilar to perform meta-analysis we aimed to provide narrative synthesis of the study 
results. 
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RESULTS 
A total of 5101 titles were identified by the 17 searches. Figures for flow through the study 
searches are given in Table 1. Only two studies[12,13] satisfied the criteria for inclusion; one 
from search 2 (early mobilisation & rehabilitation) and one from search 5 (enteral feeding). 
Meta-analysis of the data from these studies was therefore not possible. A summary 
description of both studies is given in Table 2. 
 
Quality assessment 
Both trials included in this review were open trials.  The randomisation process is well 
described in the FOOD trial[12], albeit with a slight procedural change between the pilot and 
the main phase.  The Turn-Mob trial[13] stated that randomisation took place but without 
describing the process. All patients were followed up with intention to treat and all patients 
were accounted for in both trials. Pneumonia was one of many secondary outcomes measured 
in the FOOD trial and the criteria used to make the diagnosis are unclear. In both trials there 
is potential for confounding, such as the degree of involvement by relatives in Turn-Mob 
programme, or patients switching between tube and oral feeding in the FOOD trial. 
 
 
Study results – the TurnMob trial 
Turn-Mob was a randomised trial conducted across two university hospitals in Mexico City 
from March 2006 to January 2007. 225 patients presenting with acute ischaemic stroke were 
enrolled.  Patients were randomized to standard care alone or manual turning and passive 
mobilisation plus standard care.  Standard care comprised oxygen, adequate nutrition and 
hydration, anti-platelet agents, glycaemic control, routine measurements and ‘general nursing 
care’  which included the nurses changing the position of the patients three times per day.  In 
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addition to this, the intervention group received regular changes in position (every two hours) 
and passive mobilisation of the limbs (every six hours) from a relative trained in the 
procedure by a rehabilitation physician.   
 
Of the 223 patients randomised, 48 developed HAP. There was a lower proportion with HAP 
in the intervention group (Table 2).  Recalculation of the relative risk from data supplied in 
the trial report shows a relative risk of HAP of 0.47.  All patients were followed up for 2 
weeks after discharge with no further cases identified.   
 
Study results – the FOOD trial 
The second FOOD trial, included in this review, investigated early feeding in dysphagic 
patients compared with no feeding for at least 7 days after randomisation.  Patients in the 
intervention group could receive nutrition by nasogastric (NG) tube or by percutaneous 
endoscopic gastrostomy (PEG) feeding. A total of 859 patients were recruited, of which 149 
were co-enrolled into more than one trial in the FOOD trial programme.   
 
The early intervention group had similar rates of pneumonia to the control group; case fatality 
rates for HAP were similar in both arms (intervention group 77/132, 58%; control group 
74/133, 56%).  Overall fatality rates were lower in the intervention group (182/429; 42%) 
when compared to the control group (207/430; 48%).   
 
DISCUSSION 
No eligible trials of pharmacological interventions to prevent non-critical care HAP were 
identified by the search strategy. There was some evidence from the Turn-Mob programme 
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that early mobilisation may be beneficial in select patients; results from the FOOD trial 
showed no evidence of either benefit or harm from early enteral feeding via nasogastric tube. 
 
Both trials were conducted in patients admitted with acute stroke. Such patients are known to 
be at high risk of aspiration, as swallowing dysfunction is very common in the first few days 
after an acute stroke[14]. It is questionable however whether these results are generalizable to 
the wider group of older hospitalised patients; although some of this wider group will be at 
risk of microaspiration even in the absence of overt dysphagia[15]; the mix of comorbidity, 
immune impairment and antibiotic exposure (all risk factors for HAP) may differ between 
patients with and without acute stroke. 
 
The application of the TurnMob programme depended on significant input from family 
members, in a healthcare system with significant differences to that in some developed 
countries. It is therefore not clear whether such a programme would be deliverable in other 
healthcare systems, or whether the benefits in other countries would be replicated. 
 
The lack of randomised controlled trial evidence that our search uncovered is striking; despite 
a wide search strategy encompassing multiple areas of intervention. Although healthcare 
acquired infections have been a key focus of infection control policy in recent years, much of 
the effort has focussed on Meticillin resistant Staphylococcus aureus (MRSA) infection and 
on Clostridium difficile associated diarrhoea. However, pneumonia is a common, expensive 
and dangerous healthcare acquired infection, and is beginning to garner more attention[16]. 
The evidence base for prevention lags far behind this rising level of interest. 
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A number of non-randomised studies have been published recently, which may provide the 
foundation for future well-designed RCTs. Introduction of a care bundle to enhance early 
mobility[17] was associated with a lower risk of HAP (OR 0.39; 95% CI 0.22 to 0.68, 
p=0.001), although falls rates were non-significantly higher in the early mobility group.  
Introduction of a basic nursing oral care package led to a 40% reduction in the occurrence of 
HAP compared to historical controls[18]; similar results were seen in a small study of 
neurologically impaired patients[19]. In a stroke population, the introduction of dysphagia 
screening was associated with a lower rate of HAP compared to historical controls (OR 0.43; 
95%CI 0.26 to 0.71; p=0.001)[20]. Such studies, in conjunction with the existing evidence 
base in ventilated patients, help to build the case for future trials. 
 
Strengths and Weaknesses  
The application of systematic review methodology, using prespecified criteria and focussing 
only on randomised controlled trials all contribute to the rigour of this review. We searched 
for a wide range of interventions, which enhances the utility of the review, and reinforces the 
lack of research in this area. The use of multiple databases, handsearching of references and 
inclusion of non-English language papers increases the likelihood that we have captured all 
relevant studies, although there may of course be studies that we have missed (perhaps as a 
result of examining a wide range of interventions), or which remain unpublished. 
 
The dearth of studies retrieved by this review limits the conclusions that can be drawn 
(beyond illustrating the paucity of intervention research in this area), but should not be 
viewed as a methodological weakness. The inclusion of observational studies would give 
additional information, albeit subject to the constraints of bias and confounding; a review of 
this additional literature lies outwith the boundaries of the current work however. A further 
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weakness is the lack of detailed phenotypic information about both the trial populations and 
the co-interventions that they were subject to. In particular, no information was retrievable on 
the type of pathogens causing pneumonia, on the vaccination status of the participants (for 
either influenza or pneumococcus), or on the immunocompetence of the individuals studied. 
Such information may be of considerable importance in targeting and assessing treatment 
strategies, and future trials should collect as many of these variables as possible. 
 
Recommendations for practice and future research 
Insufficient evidence currently exists to make any recommendation as to how best to prevent 
hospital acquired pneumonia in non-critical care settings. Given this lack of evidence, the 
severe nature of this common condition, studies examining the effect of interventions to 
prevent HAP are clearly required. It is important that such studies target older people (i.e. 
those who are most at risk) and that such studies target a wide range of hospitalised older 
people, not just on a condition-specific basis such as stroke. 
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Appendix ASearch Strategies 
 
Part A – Patient Interventions 
 
Search 1: 
“Pneumonia” AND [“Cross infection” OR “Hospital Acquired” OR “Health Care 
Associated” OR “Nosocomial”] AND [“Risk Assessment” OR “Scoring Tool” OR “Scoring 
System” OR “Diagnostic Tool”] 
 
Search 2: 
“Pneumonia” AND [“Cross infection” OR “Hospital Acquired” OR “Health Care 
Associated” OR “Nosocomial”] AND [“Early Mobilisation” OR “Rehabilitation”] 
 
Search 3: 
“Pneumonia” AND [“Cross infection” OR “Hospital Acquired” OR “Health Care 
Associated” OR “Nosocomial”] AND [“Dental Care” OR “Oral Hygiene” OR  
“Mouthwash” OR "Sanguinaria" OR "Chlorhexidine" OR "Benzethonium" OR 
"Benzalkonium"] 
 
Search 4: 
“Pneumonia” AND [“Cross infection” OR “Hospital Acquired” OR “Health Care 
Associated” OR “Nosocomial”] AND “Spirometry” 
 
Search 5: 
“Pneumonia” AND [“Cross infection” OR “Hospital Acquired” OR “Health Care 
Associated” OR “Nosocomial”] AND [“Intubation, Gastrointestinal” OR “NG Tube” OR 
“Nasogastric Tube” OR “NJ Tube” OR “Nasojejunal Tube” OR “Enteral Nutrition” OR 
“Enteral Feeding”] 
 
 
Part B – Medications  
 
Search 6: 
“Pneumonia” AND [“Cross infection” OR “Hospital Acquired” OR “Health Care 
Associated” OR “Nosocomial”] AND [ “Anti-Ulcer” OR “Antacids” OR “Aluminium 
Hydroxide” OR “Magnesium Carbonate” OR “Magnesium Trisilicate” OR “Hydrotalcite” 
OR “Acidex” OR “Gaviscon” OR “Peptac” OR “Histamine H2 Antagonists” OR “Histamine 
H2-receptor Antagonists” OR “Cimetidine” OR “Famotidine” OR “Nizatidine” OR 
“Ranitidine” OR “Proton Pump Inhibitors” OR “Esomeprazole” OR “Lansoprazole” OR 
“Omeprazole” OR “Pantoprazole” OR “Rabeprazole” OR “TripotassiumDicitratobismuthate” 
OR “Sucralfate” OR “Prostaglandins E, Synthetic” OR “Misoprostol”] 
 
 
Search 7: 
“Pneumonia” AND [“Cross infection” OR “Hospital Acquired” OR “Health Care 
Associated” OR “Nosocomial”] AND [“Hypnotics”OR “Sedatives” OR “Anxiolytics” OR 
“Anti-Anxiety Agents” OR “Benzodiazepines” OR “Barbiturates” OR “Antipsychotic drugs” 
OR “Diazepam” OR “Alprazolam” OR “Chlordiazepoxide” OR “Lorazepam” OR 
“Oxazepam” OR “Buspirone” OR “Meprobamate” OR “Benperidol” OR “Chlorpromazine” 
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OR “Flupentixol” OR “Flupenthixol” OR “Haloperidol” OR “Levomepromazine” OR 
“Methotrimeprazine” OR “Pericyazine” OR “Periciazine” OR “Perphenazine” OR 
“Pimozide” OR “Promazine” OR “Sulpiride” OR “Trifluoperazine” OR “Zuclopenthixol” 
OR “Amisulpride” OR “Aripiprazole” OR “Clozapine” OR “Olanzapine” OR “Paliperidone” 
OR “Quetiapine” OR “Risperidone” OR “Pipotiazine” OR “Pipothiazine” OR “Amobarbital” 
OR “Phenobarbital” OR “Butobarbital” OR “Secobarbital”] 
 
Search 8: 
“Pneumonia” AND [“Cross infection” OR “Hospital Acquired” OR “Health Care 
Associated” OR “Nosocomial”] AND [“Angiotensin-Converting Enzyme Inhibitors” OR 
“ACE inhibitors” OR “Captopril” OR “Cilazapril” OR “Enalapril” OR “Fosinopril” OR 
“Imidapril” OR “Lisinopril” OR “Moexipril” OR “Perindopril” OR “Quinapril” OR 
“Ramipril” OR “Trandolapril”] 
 
Search 9: 
“Pneumonia” AND [“Cross infection” OR “Hospital Acquired” OR “Health Care 
Associated” OR “Nosocomial”] AND [“Antibiotic Policy” OR “Antibiotic Stewardship” OR 
“Antibiotic Restriction”] 
 
Search 10: 
“Pneumonia” AND [“Cross infection” OR “Hospital Acquired” OR “Health Care 
Associated” OR “Nosocomial”] AND [“Vaccination" OR "Influenza Vaccines" OR 
"Pneumococcal Vaccines” OR "Bacterial Vaccines"OR "Mass Vaccination" 
OR"Parainfluenza Vaccines" OR"Pseudomonas Vaccines" OR "Staphylococcal Vaccines"OR 
"Vaccines, Attenuated” OR  "Vaccines, Conjugate" OR "Vaccines, Acellular" OR 
"Tuberculosis Vaccines"] 
 
Search 11: 
“Pneumonia” AND [“Cross infection” OR “Hospital Acquired” OR “Health Care 
Associated” OR “Nosocomial”] AND [“Prokinetic” OR “Gastrokinetic” OR 
“Gastroprokinetic” OR “Metoclopramide” OR “Domperidone” OR “Erythromycin” OR 
“Mitemcinal” OR “Benzamides” OR “Cisapride” OR “Mosapride” OR “Itopride” OR 
“Prucalopride” OR “Renzapride” OR “Tegaserod”] 
 
Part C– Staff interventions& Environmental Factors 
 
Search 12: 
“Pneumonia” AND [“Cross infection” OR “Hospital Acquired” OR “Health Care 
Associated” OR “Nosocomial”] AND [“Hand Washing” OR “Hand Hygiene”] 
 
Search 13: 
“Pneumonia” AND [“Cross infection” OR “Hospital Acquired” OR “Health Care 
Associated” OR “Nosocomial”] AND [“Alcohol Gel” OR “Hand Gel”] 
 
Search 14: 
“Pneumonia” AND [“Cross infection” OR “Hospital Acquired” OR “Health Care 
Associated” OR “Nosocomial”] AND [“Infection Control” OR “Barrier Nursing” OR 
“Reverse Barrier Nursing” OR “Patient Isolation”] 
 
Search 15: 
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“Pneumonia” AND [“Cross infection” OR “Hospital Acquired” OR “Health Care 
Associated” OR “Nosocomial”] AND [“Education" OR "Staff Development” OR "Education, 
Nursing, Continuing" OR "Education, Medical, Continuing" OR "Education, Continuing"OR 
"Education, Medical"] 
 
Search 16: 
“Pneumonia” AND [“Cross infection” OR “Hospital Acquired” OR “Health Care 
Associated” OR “Nosocomial”] AND [“Gloves” OR “Masks” OR “Gowns” OR “Personal 
Protective Equipment” OR “Personal Protection Equipment”] 
 
Search 17: 
“Pneumonia” AND [“Cross infection” OR “Hospital Acquired” OR “Health Care 
Associated” OR “Nosocomial”] AND [“Deep Cleaning” OR “Environmental Cleaning”] 
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Table 1. Search flowcharts 
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Table 2. Characteristics of included studies 
 
Title n Mean 
Age 
% male Study 
population 
Intervention Comparator Length of follow up Intervention 
group incidence 
Comparator 
group incidence 
Relative 
risk  
Turn Mob(13) 223 73 46 Stroke Additional 
passive 
mobilisation  
Standard Care  To discharge with follow 
up phone call at 14 days 
14/111 
(13%) 
30/112 
(27%) 
0.47 
FOOD(12) 859 76 46 Stroke Early 
Enteral tube 
feeding 
Avoid tube 
feeding for at 
least 7 days 
To discharge with follow 
up questionnaire 6 mths 
post randomisation 
132/429 
(31%) 
133/430 
(31%) 
0.99 
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